World

Pfizer-BioNTech COVID-19 vaccine gains full U.S. regulatory approval

(Reuters) – The U.S. drug regulator yesterday granted full approval to the Pfizer Inc/BioNTech SE COVID-19 vaccine – the first to secure such Food and Drug Administration validation – prompting President Joe Biden to make a fresh pitch to vaccine skeptics to get the shot to fight the relentless pandemic.

Today's Paper

The ePaper edition, on the Web & in stores for Android, iPhone & iPad.

Included free with your web subscription. Learn more.